Introduction {#sec1}
============

Flaxseed (*Linum usitatissiumum*) is one of the most consistent sources in bioactive compounds such as polyunsaturated fatty acid, fibres, proteins, antioxidants, and lignans \[[@cit0001]\]. The translation of the Latin origin of the name, meaning "very useful", is suggestive, considering the various products with biological effects that contain flaxseed and its fractions: flaxseed oil, whole seed, flaxseed meal, flaxseed mucilage and/or alcohol extracts, flaxseed hulls, ground whole seed, and flaxseed oleosomes \[[@cit0002]\]. Two major varieties of flaxseed products are available, but with different biological activity \[[@cit0001], [@cit0003]\]. Flaxseed contains one-third soluble and two-thirds insoluble fibres from a total of 35--45% of fibres. It also contains a high amount of α-linolenic acid, an essential fatty acid that cannot be synthesised by the human body \[[@cit0004]\]. Other biologically important compounds found in flaxseed products are linoleic acid, linolenic acid, alkaloids, cyclic peptides, lignans, polysaccharides, cyanogenic glycosides, and cadmium \[[@cit0002]\]. These compounds have remarkable antioxidant, hypotensive, anti-inflammatory, and hypoglycaemic activities \[[@cit0005], [@cit0006]\], being used for prevention of rheumatoid arthritis, cardiovascular (CV) diseases, and asthma \[[@cit0007]--[@cit0010]\].

A number of factors such as tumour necrosis factor (TNF), pro-inflammatory cytokines, and interleukins (IL) are responsible for increased levels of C-reactive protein (CRP), an important marker of systemic inflammation \[[@cit0011]\]. C-recative protein is also considered as a strong predictor of CV risk in comparison to several other inflammatory markers \[[@cit0012], [@cit0013]\]. Some studies suggest that this acute-phase protein marker, synthesised by the adipose tissue or by the liver, might be significantly influenced by the administration or consumption of different formulations of flaxseed, like flaxseed oil, flaxseed lignan, or flaxseed supplementation \[[@cit0014]\]. Therefore, the aim of the present study is to review available randomised clinical trials (RCTs) involving the use of different forms of flaxseed to evaluate their effectiveness on the CRP plasma concentration.

Material and methods {#sec2}
====================

Search strategy {#sec2.1}
---------------

This study was designed according to the guidelines of the 2009 preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement \[[@cit0015]\]. EMBASE, ProQuest, CINAHL, and PUBMED databases were searched using the following search terms in titles and abstracts: ("linseed" OR "flax seed" OR "flaxseed" OR "linseed meal" OR "linum usitatissimum") AND ("c reactive protein" OR "c reaction protein" OR "c-reactive protein" OR CRP OR "protein c reactive" OR "serum c reactive protein"). The wild-card term ''\*'' was used to increase the sensitivity of the search strategy. The search was limited to studies in humans published in English. The literature was searched until 1^st^ February 2016. Two reviewers (SU and M-CS) evaluated each article independently, carried out data extraction and quality assessment. Disagreements were resolved by discussion with a third party (MB).

Study selection {#sec2.2}
---------------

Original studies were included if they met the following inclusion criteria: (i) clinical trials with a case-control or cross-over design, (ii) investigation of the effect of flaxseed preparations on plasma CRP concentrations, (iii) providing baseline and end-trial plasma CRP concentrations in both flaxseed and control groups, and (iv) having a supplementation with flaxseed for at least 2 weeks.

Non-clinical studies, uncontrolled trials, and trials with insufficient data on CRP values in flaxseed and control groups were excluded from the meta-analysis.

Data extraction {#sec2.3}
---------------

Eligible studies were reviewed, and the following data were abstracted: 1) first author's name; 2) year of publication; 3) country were the study was performed; 4) study design; 5) number of participants in the flaxseed and control groups; 6) intervention assigned to the control group; 7) type (lignan extract, ground powder, or oil) and dose of flaxseed supplement; 8) treatment duration; 9) age, gender, and body mass index (BMI) of study participants; 10) systolic and diastolic blood pressures; and 11) data regarding baseline and follow-up concentrations of CRP. Data extraction was performed independently by two reviewers; disagreements were resolved by a third reviewer.

Quality assessment {#sec2.4}
------------------

Assessment of risk of bias in the studies included in the analysis was performed systematically using the Cochrane quality assessment tool for RCTs \[[@cit0016]\]. The Cochrane tool has seven criteria for quality assessment: random sequence generation (selection bias), allocation sequence concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), selective outcome reporting (reporting bias), and other potential sources of bias. The risk of bias in each study was judged to be low, high, or unclear. Risk-of-bias assessment was performed independently by two reviewers; disagreements were resolved by a third reviewer.

Quantitative data synthesis {#sec2.5}
---------------------------

Meta-analysis was conducted using Comprehensive Meta-Analysis (CMA) V2 software (Biostat, NJ) \[[@cit0017]\]. Net changes in measurements (change scores) were calculated as follows: measure at end of follow-up − measure at baseline. For single-arm, cross-over trials, the net change in plasma concentrations of CRP were calculated by subtracting the value after control intervention from that reported after treatment. All values were collated as mg/l. Standard deviations (SDs) of the mean difference were calculated using the following formula: SD = square root \[(SD~pre-treatment~)^2^ + (SD~post-treatment~)^2^ -- (2 R × SD~pre-treatment~ × SD~post-treatment~)\], assuming a correlation coefficient (R) equal to 0.5. If the outcome measures were reported in median and range (or 95% confidence interval (CI)), mean and standard SD values were estimated using the method described by Wan *et al.* \[[@cit0018]\] Where standard error of the mean (SEM) only was reported, the standard deviation (SD) was estimated using the following formula: SD = SEM × sqrt (*n*), where *n* is the number of subjects.

Net changes in measurements (change scores) were calculated for parallel and cross-over trials, as follows: (measure at the end of follow-up in the treatment group -- measure at baseline in the treatment group) -- (measure at the end of follow-up in the control group -- measure at baseline in the control group). A random-effects model (using DerSimonian-Laird method) and the generic inverse variance method were used to compensate for the heterogeneity of studies in terms of study design, treatment duration, and the characteristics of populations being studied \[[@cit0019]\]. Inter-study heterogeneity was assessed using Cochran Q test and *I^2^* index. In order to evaluate the influence of each study on the overall effect size, sensitivity analysis was conducted using the leave-one-out method, i.e. iteratively removing one study each time and repeating the analysis.

Meta-regression {#sec2.6}
---------------

A weighted random-effects meta-regression using an unrestricted maximum likelihood model was performed to assess the association between the overall estimate of effect size with potential moderator variables, including dose and duration of supplementation with flaxseed.

Publication bias {#sec2.7}
----------------

Potential publication bias was explored using visual inspection of Begg's funnel plot asymmetry, and Begg's rank correlation and Egger's weighted regression tests. The Duval and Tweedie "trim and fill" method was used to adjust the analysis for the effects of publication bias \[[@cit0020]\].

Results {#sec3}
=======

Search results and trial flow {#sec3.1}
-----------------------------

The initial screening comprised 587 full text articles, and we removed the articles with titles that were obviously irrelevant. Selected articles were hand searched to identify further relevant studies. Among 19 full text articles assessed for eligibility, two studies were excluded, being not controlled for flaxseed supplementation ([Figure 1](#f0001){ref-type="fig"}). After final assessment, 17 eligible trials achieved the inclusion criteria and were preferred for the final meta-analysis \[[@cit0007], [@cit0021]--[@cit0036]\].

![Flow chart of the number of studies identified and included into the meta-analysis](AMS-15-34567-g001){#f0001}

Characteristics of included studies {#sec3.2}
-----------------------------------

In total, 1256 individuals were included to the meta-analysis, 639 participants were allocated to the flaxseed supplementation group and 617 to the control group. The number of participants in the analysed studies ranged from nine to 85 in the flaxseed group and from eight to 94 in the control group. The included studies were published between 2007 and 2015, and were conducted in the USA (*n* = 5), Brazil (*n* = 4), Canada (*n* = 3), China (*n* = 2), Greece, Denmark, and Iran. The following flaxseed supplementation was administered in the included trials: ground powder 13 g to 60 g/day (2.9 g to 10 g ALA/day), oil containing 1.022 g to 8 g ALA/day, and derived lignan complex 360 mg to 600 mg total SDG/day. Duration of flaxseed supplementation ranged between 2 weeks and 12 months. Ten trials were designed as a parallel group and seven as crossover studies. [Table I](#t0001){ref-type="table"} shows the demographic characteristics and baseline parameters of the included studies. No adverse events related to the supplementation were reported.

###### 

Demographic characteristics and baseline parameters of the studies selected for analysis

  Parameter                                      Study                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  ---------------------------------------------- ------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ----------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------- ------------------------------------------------------------------------------- ------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------
  Year                                           2013                                                         2013                                                                                                                       2013                                                                                        2012                                                                                                                                                                                    2012                                                                             2011                                                  2011                                                                                                                         2009                                                                                                                                                                        2008                                                                                                                            2008                                                                                    2008                                                                            2008                                                               2007                                                                                                                              2007                                                                                                                                                                                 2015                                                                                                                                                                                                                                              2008                                                                                                                                               2013
  Location                                       Greece                                                       USA                                                                                                                        China                                                                                       Canada                                                                                                                                                                                  Brazil                                                                           USA                                                   Brazil                                                                                                                       China                                                                                                                                                                       Canada                                                                                                                          USA                                                                                     Denmark                                                                         Canada                                                             USA                                                                                                                               Brazil                                                                                                                                                                               Brazil                                                                                                                                                                                                                                            USA                                                                                                                                                Iran
  Design                                         Randomized, placebo-controlled crossover group trial         Randomized, placebo-controlled crossover group trial                                                                       Randomized single-blind placebo-controlled parallel group trial                             Randomized double-blind placebo-controlled crossover group trial                                                                                                                        Randomized double-blind, multicentre, placebo-controlled parallel group trial    Randomized placebo-controlled crossover group trial   Randomized double-blind placebo-controlled parallel- group trial                                                             Randomized double-blind crossover group trial                                                                                                                               Randomized double-blind placebo-controlled parallel group trial                                                                 Randomized double-blind placebo-controlled parallel group trial                         Randomized double-blind placebo-controlled crossover group trial                Randomized double-blind placebo-controlled parallel- group trial   Randomized controlled parallel- group trial                                                                                       Randomized double-blind placebo-controlled crossover group trial                                                                                                                     Randomized single blind controlled parallel- group trial                                                                                                                                                                                          Randomized, multicentre, controlled parallel group trial                                                                                           Randomized, unblinded, controlled parallel group trial
  Duration of trial                              6 weeks                                                      12 weeks                                                                                                                   12 weeks                                                                                    3 months                                                                                                                                                                                4 months                                                                         12 weeks                                              12 weeks                                                                                                                     12 weeks                                                                                                                                                                    12 months                                                                                                                       10 weeks                                                                                6 weeks                                                                         12 weeks                                                           8 weeks                                                                                                                           2 weeks                                                                                                                                                                              42 days                                                                                                                                                                                                                                           30 days                                                                                                                                            8 weeks
  Inclusion criteria                             Healthy, normal weight males and females aged 18--35 years   Overweight or obese men and postmenopausal women with pre- diabetes (impaired fasting glucose between 100 and 125 mg/dl)   Individuals screened for metabolic syndrome following low-intensive lifestyle counselling   Patients 55 years of age or older, being postmenopausal (no menstruation for at least one year), not on insulin or changing exercise patterns, and healthy aside from type 2 diabetes   Patients with terminal renal failure who were undergoing chronic haemodialysis   Obese glucose intolerant people                       Active males or females 18--65 years-old with BMI \> 40 kg/m^2^, or \> 35 kg/m^2^ with comorbidities, plus hsCRP \> 5 mg/l   Type 2 diabetic patients 50--79 years of age (women postmenopausal for at least 1-year); LDL-C level \> 2.9 mmol/l, and not using exogenous insulin for glycaemic control   Women with at least 6 months of amenorrhea in the year before entry into the study and a normal mammogram in the past 2 years   Men and post-menopausal women between the ages of 44 and 75 with hypercholesterolemia   Healthy postmenopausal women (defined as no menstrual period for \> 24 month)   Healthy male and female volunteers                                 Healthy adult males and females abdominally overweight/obese (WC \> 81 cm for females; WC \> 94 cm for males) aged 20--68 years   Males and females, 18--65 years old, BMI \> 40 kg/m^2^ (or \> 35 kg/m^2^ with comorbidities), non-hospitalized and receiving oral diet, with elevated C-reactive protein \> 5 mg/l   Males with at least three of the following cardiovascular risk factors: WC ≥ 90 cm; BMI ≥ 25 kg/m^2^; fasting TC ≥ 200 mg/dl, LDL-C ≥ 130 mg/dl, HDL-C \< 40 mg/dl, TG ≥ 150 mg/dl; glycemia ≥ 100 mg/dl; SBP ≥ 140 mm Hg and/or DBP ≥ 90 mm Hg   Patients with biopsy-confirmed prostatic carcinoma electing prostatectomy as their primary treatment and at least 21 days from scheduled surgery   Adult haemodialysis patients with dyslipidaemia (TG \> 200 mg/dl and/or HDL-C \< 40 mg/dl) aged between 23 and 77 years
  Flaxseed form                                  Flaxseed oil                                                 Ground flaxseed powder                                                                                                     Ground flaxseed powder                                                                      Flaxseed lignan complex                                                                                                                                                                 Flaxseed oil                                                                     Ground flaxseed powder                                Ground flaxseed powder                                                                                                       Flaxseed lignan complex                                                                                                                                                     Ground flaxseed powder                                                                                                          Ground flaxseed powder                                                                  Flaxseed lignan complex                                                         Flaxseed oil                                                       Flaxseed oil                                                                                                                      Ground flaxseed powder                                                                                                                                                               Ground flaxseed powder                                                                                                                                                                                                                            Ground flaxseed powder                                                                                                                             Ground flaxseed powder
  Flaxseed intervention                          15 ml/day containing 8 g of ALA                              13 g ground flaxseed containing 2.9 g of ALA                                                                               30 g ground whole flaxseed providing 7 g ALA                                                4 capsules -- 600 mg total SDG/day                                                                                                                                                      2 g/day (2 capsules)                                                             40 g/day                                              60 g/day containing 10 g ALA/day                                                                                             3 capsules -- 360 mg total SDG/day                                                                                                                                          40 g/day[\*\*](#tf1-2){ref-type="fn"}                                                                                           40 g/day                                                                                500 mg total SDG/day                                                            2 g/day (2 capsules) containing 1022 mg of ALA/day                 \~11.6 g ALA/day                                                                                                                  30 g/day \~5 g of ALA                                                                                                                                                                60 g/day                                                                                                                                                                                                                                          30 g/day                                                                                                                                           40 g/day
  26 g ground flaxseed containing 5.8 g of ALA   30 g /day + low-fat diet                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Participants:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
   Case                                          37                                                           25                                                                                                                         83                                                                                          16                                                                                                                                                                                      70                                                                               9                                                     10                                                                                                                           70                                                                                                                                                                          85                                                                                                                              30                                                                                      22                                                                              22                                                                 27                                                                                                                                24                                                                                                                                                                                   14                                                                                                                                                                                                                                                40                                                                                                                                                 15
  40                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
   Control                                       90                                                           75                                                                                                                         8                                                                                           94                                                                                                                                                                                      32                                                                               22                                                    24                                                                                                                           13                                                                                                                                                                          41                                                                                                                              15                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Age \[years\]:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
   Case                                          25.6 ±5.9                                                    58.6 ±6.3                                                                                                                  48.9 ±8.1                                                                                   66.2 ±1.7[\*](#tf1-1){ref-type="fn"}                                                                                                                                                    55.7 ±13.0                                                                       54.7 ±6.6                                             47.8 ±8.0[\*](#tf1-1){ref-type="fn"}                                                                                         62.9 ±7.5                                                                                                                                                                   54.0 ±4.0                                                                                                                       56.8 ±7.3                                                                               61 ±7                                                                           34.70 ±1.69[\*](#tf1-1){ref-type="fn"}                             37.74 ±11.8                                                                                                                       40.8 ±11.6                                                                                                                                                                           40 ±9                                                                                                                                                                                                                                             60.2 ±7.0                                                                                                                                          54.0 ±4.0[\*](#tf1-1){ref-type="fn"}
  59.3 ±7.6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
   Control                                       48.7 ±7.9                                                    58.3 ±14.8                                                                                                                 50.7 ±6.4[\*](#tf1-1){ref-type="fn"}                                                        55.4 ±4.5                                                                                                                                                                               57.0 ±8.0                                                                        32.93 ±1.99[\*](#tf1-1){ref-type="fn"}                39.42 ±10.45                                                                                                                 33 ±10                                                                                                                                                                      58.2 ±6.8                                                                                                                       54.5 ±4.0[\*](#tf1-1){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  Male (%):                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
   Case                                          21.62                                                        44.0                                                                                                                       56.6                                                                                        NS                                                                                                                                                                                      55.7                                                                             44.4                                                  NS                                                                                                                           37.14                                                                                                                                                                       0.0                                                                                                                             53.33                                                                                   0.0                                                                             NS                                                                 21.0                                                                                                                              17.7                                                                                                                                                                                 100.0                                                                                                                                                                                                                                             100.0                                                                                                                                              66.6
  100.0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
   Control                                       55.6                                                         61.3                                                                                                                       NS                                                                                          0.0                                                                                                                                                                                     46.87                                                                            NS                                                    22.0                                                                                                                         100.0                                                                                                                                                                       100.0                                                                                                                           40.0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  BMI \[kg/m^2^\]:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
   Case                                          21.9 ±2.5                                                    30.4 ±5.3                                                                                                                  25.1 ±2.3                                                                                   31.2 ±2.2[\*](#tf1-1){ref-type="fn"}                                                                                                                                                    25.1 ±3.47                                                                       32.4 ±8.2                                             44.0 ±3.9[\*](#tf1-1){ref-type="fn"}                                                                                         24.2 ±0.7                                                                                                                                                                   25.5 ±4.5                                                                                                                       27.4 ±4.4                                                                               24.1 ±3.4                                                                       28.32 ±0.46[\*](#tf1-1){ref-type="fn"}                             29.31 ±4.27                                                                                                                       47.1 ±7.2                                                                                                                                                                            32 ±3                                                                                                                                                                                                                                             28.5 ±3.9                                                                                                                                          25.5 ±2.0[\*](#tf1-1){ref-type="fn"}
  28.5 ±4.5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
   Control                                       22.0 ±2.6                                                    25.5 ±2.4                                                                                                                  24.2 ±4.27                                                                                  32.0 ±8.3                                                                                                                                                                               45.2 ±4.2[\*](#tf1-1){ref-type="fn"}                                             24.4 ±0.7                                             26.8 ±4.6                                                                                                                    28.1 ±5.1                                                                                                                                                                   28.77 ±0.78[\*](#tf1-1){ref-type="fn"}                                                                                          30.23 ±4.14                                                                             47.2 ±7.2                                                                       32.1 ±2.8                                                          28.8 ±4.0                                                                                                                         27.0 ±1.0[\*](#tf1-1){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  hs-CRP \[mg/l\]:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
   Case                                          0.45 ±0.47                                                   3.0 ±3.2                                                                                                                   1.01 (0.72--2.12)                                                                           2.4 ±1.1[\*](#tf1-1){ref-type="fn"}                                                                                                                                                     8.0 (2.3--16.8)                                                                  3.6 ±1.7                                              12.9 ±7.2[\*](#tf1-1){ref-type="fn"}                                                                                         1.67 ±0.19[\*](#tf1-1){ref-type="fn"}                                                                                                                                       2.02 ±2.60                                                                                                                      1.36 (0.85--2.7)[^\#^](#tf1-3){ref-type="fn"}                                           0.88 (0.63--2.05)[^\#^](#tf1-3){ref-type="fn"}                                  319 ±65[\*](#tf1-1){ref-type="fn"}                                 2.40 ±2.39                                                                                                                        13.7 ±9.9                                                                                                                                                                            2.04 ±1.48                                                                                                                                                                                                                                        1.4 (1.0--2.7)[^\#\#^](#tf1-4){ref-type="fn"}                                                                                                      4.8 ±0.9[\*](#tf1-1){ref-type="fn"}
  3.2 ±2.8                                       1.2 (0.9--2.5)[^\#\#^](#tf1-4){ref-type="fn"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
   Control                                       0.66 ±1.06                                                   2.9 ±3.0                                                                                                                   1.12 (0.75--1.97)                                                                           2.7 ±1.2[\*](#tf1-1){ref-type="fn"}                                                                                                                                                     4.4 (2.3--7.6)                                                                   3.6 ±1.7                                              10.5 ±5.5[\*](#tf1-1){ref-type="fn"}                                                                                         1.42 ±0.19[\*](#tf1-1){ref-type="fn"}                                                                                                                                       2.18 ±2.29                                                                                                                      1.06 (0.37--1.7)[^\#^](#tf1-3){ref-type="fn"}                                           0.80 (0.62--1.62)[^\#^](#tf1-3){ref-type="fn"}                                  314 ±69[\*](#tf1-1){ref-type="fn"}                                 2.79 ±1.80                                                                                                                        11.8 ±8.2                                                                                                                                                                            2.76 ±2.45                                                                                                                                                                                                                                        1.5 (1.1--2.2)[^\#\#^](#tf1-4){ref-type="fn"}                                                                                                      4.0 ±0.6[\*](#tf1-1){ref-type="fn"}
  SBP \[mm Hg\]:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
   Case                                          NS                                                           NS                                                                                                                         134.4 ±17.0                                                                                 133.6 ±4.8[\*](#tf1-1){ref-type="fn"}                                                                                                                                                   NS                                                                               NS                                                    126 ±10[\*](#tf1-1){ref-type="fn"}                                                                                           124 ±3                                                                                                                                                                      125.4 ±14.5                                                                                                                     NS                                                                                      124 ±13                                                                         NS                                                                 NS                                                                                                                                NS                                                                                                                                                                                   139 ±20.3                                                                                                                                                                                                                                         NS                                                                                                                                                 NS
  NS                                             NS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
   Control                                       NS                                                           NS                                                                                                                         134.5 ±14.5                                                                                 135.8 ±4.3[\*](#tf1-1){ref-type="fn"}                                                                                                                                                   NS                                                                               NS                                                    138 ±25[\*](#tf1-1){ref-type="fn"}                                                                                           123 ±3                                                                                                                                                                      122.4 ±15.5                                                                                                                     NS                                                                                      NS                                                                              NS                                                                 NS                                                                                                                                134 ±9.2                                                                                                                                                                             NS                                                                                                                                                                                                                                                NS                                                                                                                                                 
  DBP \[mm Hg\]:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
   Case                                          NS                                                           NS                                                                                                                         86.3 ±11.3                                                                                  82.1 ±1.9[\*](#tf1-1){ref-type="fn"}                                                                                                                                                    NS                                                                               NS                                                    79 ±3[\*](#tf1-1){ref-type="fn"}                                                                                             79.2 ±10.7                                                                                                                                                                  79.7 ±9.4                                                                                                                       NS                                                                                      75 ±8                                                                           NS                                                                 NS                                                                                                                                NS                                                                                                                                                                                   83 ±13.5                                                                                                                                                                                                                                          NS                                                                                                                                                 NS
  NS                                             NS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
   Control                                       NS                                                           NS                                                                                                                         85.9 ±8.8                                                                                   84.5 ±2.2[\*](#tf1-1){ref-type="fn"}                                                                                                                                                    NS                                                                               NS                                                    92 ±16[\*](#tf1-1){ref-type="fn"}                                                                                            79.3 ±10.3                                                                                                                                                                  77.7 ±9.4                                                                                                                       NS                                                                                      NS                                                                              NS                                                                 NS                                                                                                                                80 ±7.7                                                                                                                                                                              NS                                                                                                                                                                                                                                                NS                                                                                                                                                 

Values are expressed as mean ± SD or median (range)

values are means ± SEM

half of the daily amount was given as two slices of bread, which replaced the usual bread in the diet, and the other 20 g was provided as ground grains to add to cereal, juice, or yogurt, depending of the food preferences of the women

median (IQR)

median (95% CI).

BMI -- body mass index, NS -- not stated, SBP -- systolic blood pressure, DBP -- diastolic blood pressure, hs-CRP -- high-sensitivity C-reactive protein, BMI -- body mass index, CHD -- coronary heart disease, ALA -- α-linolenic acid, SDG -- secoisolariciresinol diglucoside, WC -- waist circumference, LDL-C -- low-density lipoprotein cholesterol, HDL-C -- high-density lipoprotein cholesterol, TG -- triglycerides.

Risk of bias assessment {#sec3.3}
-----------------------

An unclear risk of bias with respect to sequence generation and allocation concealment was observed. Some trials were not blinded, but studies were low risk in terms of other sources of bias. The systematic assessment of bias in the included studies is shown in [Table II](#t0002){ref-type="table"}.

###### 

Assessment of risk of bias in the included studies using Cochrane criteria

  Study                                             Sequence generation   Allocation concealment   Blinding of participants and personnel   Blinding of outcome assessment   Incomplete outcome data   Selective outcome reporting   Other potential threats to validity
  ------------------------------------------------- --------------------- ------------------------ ---------------------------------------- -------------------------------- ------------------------- ----------------------------- -------------------------------------
  Kontogianni *et al.* 2013 \[[@cit0021]\]          U                     U                        H                                        L                                L                         L                             L
  Hutchins *et al.* 2013 \[[@cit0022]\]             U                     U                        H                                        L                                L                         L                             L
  Zong *et al.* 2013 \[[@cit0023]\]                 U                     U                        H                                        L                                L                         L                             L
  Barre *et al.* 2012 \[[@cit0024]\]                U                     U                        L                                        L                                L                         L                             L
  Lemos *et al.* 2012 \[[@cit0025]\]                U                     U                        L                                        L                                L                         L                             L
  Rhee *et al.* 2011 \[[@cit0026]\]                 U                     U                        H                                        L                                L                         L                             L
  Faintuch *et al.* 2011 \[[@cit0027]\]             U                     U                        L                                        L                                L                         L                             L
  Pan *et al.* 2009 \[[@cit0028]\]                  L                     L                        L                                        L                                L                         L                             L
  Dodin *et al.* 2008 \[[@cit0029]\]                L                     L                        L                                        L                                L                         L                             L
  Bloedon *et al.* 2008 \[[@cit0030]\]              U                     U                        L                                        L                                L                         L                             L
  Hallund *et al.* 2008 \[[@cit0031]\]              U                     U                        L                                        L                                L                         L                             L
  Kaul *et al.* 2008 \[[@cit0032]\]                 L                     L                        L                                        L                                L                         L                             L
  Nelson *et al.* 2007 \[[@cit0033]\]               U                     U                        H                                        H                                L                         L                             L
  Faintuch *et al.* 2007 \[[@cit0034]\]             U                     U                        L                                        L                                L                         L                             L
  Cassani *et al.* 2015 \[[@cit0035]\]              U                     U                        U                                        U                                L                         L                             L
  Demark-Wahnefried *et al.* 2008 \[[@cit0036]\]    L                     L                        H                                        L                                L                         L                             L
  Khalatbari Soltani *et al.* 2013 \[[@cit0006]\]   U                     U                        H                                        U                                L                         L                             L

L -- low risk of bias, H -- high risk of bias, U -- unclear risk of bias.

Effect of flaxseed supplementation on plasma CRP concentrations {#sec3.4}
---------------------------------------------------------------

Meta-analysis of data from 17 trials did not suggest a significant change in plasma CRP concentrations following supplementation with flaxseed-containing products (WMD: --0.25 mg/l, 95% CI: --0.53, 0.02, *p* = 0.074; *Q* = 46.33, *I* ^2^ = 61.15%) ([Figure 2 A](#f0002){ref-type="fig"}). The effect size was robust in the leave-one-out sensitivity analysis ([Figure 2 B](#f0002){ref-type="fig"}). Subgroup analysis did not suggest any significant difference in terms of changing plasma CRP concentrations among different types of flaxseed supplements used in the included studies, i.e. flaxseed oil (WMD: --0.67 mg/l, 95% CI: --2.00, 0.65, *p* = 0.32; *Q* = 28.63, *I* ^2^ = 82.54%) ([Figure 3 A](#f0003){ref-type="fig"}), lignan extract (WMD: --0.32 mg/l, 95% CI: --0.71, 0.06, *p* = 0.103; *Q* = 0.02, *I* ^2^ = 0%) ([Figure 3 B](#f0003){ref-type="fig"}), and ground powder (WMD: --0.18 mg/l, 95% CI: --0.42, 0.06, *p* = 0.142; *Q* = 13.44, *I* ^2^ = 33.06%) ([Figure 3 C](#f0003){ref-type="fig"}).

![Forest plot displaying weighted mean difference and 95% confidence intervals for the impact of flaxseed supplementation on plasma C-reactive protein concentrations. Lower plot shows leave-one-out sensitivity analysis](AMS-15-34567-g002){#f0002}

![Forest plot displaying weighted mean difference and 95% confidence intervals for the impact of flaxseed oil (**A**), lignan extract (**B**), and ground powder (**C**) on plasma C-reactive protein concentrations](AMS-15-34567-g003){#f0003}

Meta-regression {#sec3.5}
---------------

Meta-regression analysis was conducted to evaluate the association between changes in plasma CRP concentrations and potential confounders, including duration of supplementation with flaxseed and changes in plasma LDL-C concentrations. No significant association was found between changes in plasma CRP levels with either supplementation duration (slope: --0.001; 95% CI: --0.02 to 0.02; *p* = 0.928) or plasma LDL-C changes (slope: 0.05; 95% CI: --0.01 to 0.12; *p* = 0.095) ([Figure 4](#f0004){ref-type="fig"}).

![Meta-regression plots of the association between mean changes in plasma C-reactive protein concentrations with duration of supplementation and changes in plasma LDL-C concentrations](AMS-15-34567-g004){#f0004}

Publication bias {#sec3.6}
----------------

Visual inspection of funnel plots suggested an asymmetry in the meta-analyses of flaxseed's effects on plasma CRP concentrations. Using a "trim and fill" method six potentially missing studies were imputed on the right side of the funnel plot ([Figure 5](#f0005){ref-type="fig"}). However, the corrected effect size remained non-significant after imputation (WMD: --0.10 mg/l, 95% CI: --0.42, 0.22). The results of Egger's linear regression (intercept = --0.86, standard error = 0.35; 95% CI: --1.59, --0.12, *t* = 2.44, d*f* = 18, two-tailed *p* = 0.025) but not Begg's rank correlation (Kendall's τ with continuity correction = --0.19, *z* = 1.20, two-tailed *p* = 0.223) suggested publication bias in the meta-analysis.

![Funnel plot displaying publication bias in the studies reporting the impact of flaxseed supplementation on plasma C-reactive protein concentrations](AMS-15-34567-g005){#f0005}

Discussion {#sec4}
==========

This meta-analysis did not suggest a significant change in plasma CRP concentrations following supplementation with flaxseed-containing products. Subgroup analysis also did not suggest any significant difference in terms of changing plasma CRP concentrations among different types of flaxseed supplements used in the included studies, i.e. flaxseed oil, lignan extract, and ground powder.

A reason for these effects could be that flaxseed oil does not contain eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) fatty acids, while the presence of α-linolenic acid may not be sufficient for such beneficial effects \[[@cit0008]\]. Despite the fact that α-linolenic acid undergoes conversions to longer-chain n-3 polyunsaturated fatty acids or essential fatty acids such as EPA, docosapentaenoic acid (DPA), and DHA, the exact percentage of these conversions in the cells, plasma, and tissues are still not known \[[@cit0037]\]. The α-linolenic acid contained in flaxseed products was shown to inhibit the metabolisation of arachidonic acid to more inflammatory cytokines \[[@cit0038]\]. Furthermore, different factors such as smoking, gender, and high intake of long-chain n-3 polyunsaturated fatty acids were shown to affect the metabolic capacity of α-linolenic acid conversions \[[@cit0039], [@cit0040]\]. It has been shown that younger women have a greater capacity of conversion of α-linolenic acid to essential fatty acids than older women and men, due to having a hormonal profile more sensitive to diet \[[@cit0041]\]. This capacity of conversion of α-linolenic acid to essential fatty acids is even greater during the period of pregnancy and lactation.

Another fact that may account for these results is that less than 10% of dietary α-linolenic acid is incorporated in the plasma phospholipid pool \[[@cit0042]\]. Moreover, the beneficial effects of α-linolenic acid derived from plant sources, which is less effective than omega-3 obtained from animal sources, might also influence the results on flaxseed supplements and products on plasma CRP levels.

Lignans, the precursors of enterodiol and enterolactone, are also important compounds found in flaxseed products converted by the microbial flora in the colon \[[@cit0008], [@cit0043]\]. The administration of the principal lignan of flaxseed, secoisolariciresinol diglucoside and its primary metabolites: secoisolariciresinol (SECO), enterodiol (ED), and enterolactone (EL), on male Wistar rats, showed short half-lives, a large volume of distribution, and a high systemic clearance \[[@cit0044]\]. These pharmacokinetics properties of lignans might also explain the lack of effects of flaxseed products on plasma CRP levels. Another potential reason may lie in the fact that the effects of fatty acids on inflammatory cells are modulated by changes in fatty acid composition of cell membranes, causing lipid raft production, changes of membrane fluidity, and modifications of gene expression and of the pattern of peptide and lipid mediator production \[[@cit0045]--[@cit0050]\].

The present meta-analysis has some limitations. There were only a few eligible RCTs, and most of them had a small number of participants with suitable short time of supplementation, and they were heterogeneous regarding the characteristics of patients and study design. Many characteristics that vary within studies, such as the type of flaxseed products, the background of the patients included, the control groups, or the quality of the studies, could have been factors of between-study heterogeneity. Our results showed that the significance of estimated pooled effect size was not biased by any single study.

In conclusion, this meta-analysis of available randomised controlled trials does not suggest any significant benefit of flaxseed product supplementation in decreasing plasma CRP concentrations. Larger, well-designed studies with higher doses and longer follow-up should be performed to validate the current results.

The meta-analysis was prepared within the Lipid and Blood Pressure Meta-Analysis Collaboration (LBPMC) Group ([www.lbpmcgroup.umed.pl](http://www.lbpmcgroup.umed.pl)).
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